Alpha-synuclein (SNCA) polymorphisms and susceptibility to Parkinson's disease: A meta-analysis

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 168, Issue 2, 2015, Pages 123-134

  Han, Wei ^a   Liu, Yingli ^a   Mi, Yingjun ^a   Zhao, Jing ^a   Liu, Dianwu ^a   Tian, Qingbao ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Disease; Meta analysis; Parkinson's; Polymorphisms; SNCA

Indexed keywords

ALPHA SYNUCLEIN; SNCA PROTEIN, HUMAN;

ARTICLE; CONFIDENCE INTERVAL; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; MEDLINE; META ANALYSIS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; PUBLISHING; RISK FACTOR;

ALPHA-SYNUCLEIN; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; RISK FACTORS;

EID: 84923094443     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32288     Document Type: Article

References (36)

1. Benmoyal-Segal L, Soreq H. 2006. "Gene-environment interactions in sporadic Parkinson's disease. ". J. Neurochem. 97(6):1740-1755.
2. Benmoyal-Segal L, Vander T, Shifman S, Bryk B, Ebstein RP, Marcus EL, Stessman J, Darvasi A, Herishanu Y, Friedman A, Soreq H. 2005. "Acetylcholinesterase/paraoxonase interactions increase the risk of insecticide-induced Parkinson's disease.". FASEB J 19(3):452-454.
3. Botta-Orfila T, Ezquerra M, Rios J, Fernandez-Santiago R, Cervantes S, Samaranch L, Pastor P, Marti MJ, Munoz E, Valldeoriola F, Aguilar M, Calopa M, Hernandez-Vara J, Tolosa E. 2011. "Lack of interaction of SNCA and MAPT genotypes in Parkinson's disease." Euro J Neurol 18(3):e32.
4. Chang X L, X. Y. Mao H H Li, J. H. Zhang N N Li, J. M. Burgunder R Peng. 2011. "Association of GWAS loci with PD in China.". Am J Med Genet B, Neuropsychiatr Genet 156B(3):334-339.
5. Chung SJ, Armasu SM, Anderson KJ, Biernacka JM, Lesnick TG, Rider DN, Cunningham JM, Ahlskog JE, Frigerio R, Maraganore DM. 2013. "Genetic susceptibility loci, environmental exposures, and Parkinson's disease: a case-control study of gene-environment interactions. " Parkinsonism Relat Disord 19(6):595-599.
6. Dick FD, De Palma G, Ahmadi A, Osborne A, Scott NW, Prescott GJ, Bennett J, Semple S, Dick S, Mozzoni P, Haites N, Wettinger SB, Mutti A, Otelea M, Seaton A, Soderkvist P, Felice A. 2007. "Gene-environment interactions in parkinsonism and Parkinson's disease: the Geoparkinson study. " Occup Environ Med 64(10):673-680.
7. Elbaz A, Ross OA, Ioannidis JP, Soto-Ortolaza AI, Moisan F, Aasly J, Annesi G, Bozi M, Brighina L, Chartier-Harlin MC, Destee A, Ferrarese C, Ferraris A, Gibson JM, Gispert S, Hadjigeorgiou GM, Jasinska-Myga B, Klein C, Kruger R, Lambert JC, Lohmann K, van de Loo S, Loriot MA, Lynch T, Mellick GD, Mutez E, Nilsson C, Opala G, Puschmann A, Quattrone A, Sharma M, Silburn PA, Stefanis L, Uitti RJ, Valente EM, Vilarino-Guell C, Wirdefeldt K, Wszolek ZK, Xiromerisiou G, Maraganore DM, Farrer MJ. 2011. "Independent and joint effects of the MAPT and SNCA genes in Parkinson disease. " Ann Neurol 69(5):778-792.
8. Farrer M, Maraganore DM, Lockhart P, Singleton A, Lesnick TG, de Andrade M, West A, de Silva R, Hardy J, Hernandez D. 2001. "alpha-Synuclein gene haplotypes are associated with Parkinson's disease. " Hum Mol Genet 10(17):1847-1851.
9. Fung HC, Scholz S, Matarin M, Simon-Sanchez J, Hernandez D, Britton A, Gibbs JR, Langefeld C, Stiegert ML, Schymick J, Okun MS, Mandel RJ, Fernandez HH, Foote KD, Rodriguez RL, Peckham E, De Vrieze FW, Gwinn-Hardy K, Hardy JA, Singleton A. 2006. "Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data. " Lancet Neurol 5(11):911-916.
10. Gatto NM, Rhodes SL, Manthripragada AD, Bronstein J, Cockburn M, Farrer M, Ritz B. 2010. "alpha-Synuclein gene may interact with environmental factors in increasing risk of Parkinson's disease. " Neuroepidemiology 35(3):191-195.
11. Hamza TH, Chen H, Hill-Burns EM, Rhodes SL, Montimurro J, Kay DM, Tenesa A, Kusel VI, Sheehan P, Eaaswarkhanth M, Yearout D, Samii A, Roberts JW, Agarwal P, Bordelon Y, Park Y, Wang L, Gao J, Vance JM, Kendler KS, Bacanu SA, Scott WK, Ritz B, Nutt J, Factor SA, Zabetian CP, Payami H. 2011. "Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffee. " PLoS Genet 7(8):e1002237.
12. Henchcliffe C, Beal MF. 2008. "Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. " Nature clinical practice. Neurology 4(11):600-609.
13. Hu Y, Tang B, Guo J, Wu X, Sun Q, Shi C, Hu L, Wang C, Wang L, Tan L, Shen L, Yan X, Zhang H. 2012. "Variant in the 3' region of SNCA associated with Parkinson's disease and serum alpha-synuclein levels. " J Neurol 259(3):497-504.
14. Kenborg L, Lassen CF, Ritz B, Schernhammer ES, Hansen J, Gatto NM, Olsen JH. 2011. "Outdoor work and risk for Parkinson's disease: a population-based case-control study. " Occup Environ Med 68(4):273-278.
15. Lau J, Ioannidis J P, Schmid C H. 1997. "Quantitative synthesis in systematic reviews. " Ann Intern Med 127(9):820-826.
16. Li S C, Schoenberg B S, Wang C C, Cheng X M, Rui D Y, Bolis C L, Schoenberg D G. 1985. "A prevalence survey of Parkinson's disease and other movement disorders in the People's Republic of China. " Arch Neurol 42(7):655-657.
17. Mantel N, Haenszel W. 1959. "Statistical aspects of the analysis of data from retrospective studies of disease. " J Natl Cancer Inst 22(4):719-748.
18. Mata IF, Shi M, Agarwal P, Chung KA, Edwards KL, Factor SA, Galasko DR, Ginghina C, Griffith A, Higgins DS, Kay DM, Kim H, Leverenz JB, Quinn JF, Roberts JW, Samii A, Snapinn KW, Tsuang DW, Yearout D, Zhang J, Payami H, Zabetian C P. 2010. "SNCA variant associated with Parkinson disease and plasma alpha-synuclein level." Arch Neurol 67(11):1350-1356.
19. Mizuta I, Satake W, Nakabayashi Y, Ito C, Suzuki S, Momose Y, Nagai Y, Oka A, Inoko H, Fukae J, Saito Y, Sawabe M, Murayama S, Yamamoto M, Hattori N, Murata M, Toda T. 2006. "Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease." Hum Mol Genet 15(7):1151-1158.
20. Mueller JC, Fuchs J, Hofer A, Zimprich A, Lichtner P, Illig T, Berg D, Wullner U, Meitinger T, Gasser T. 2005. "Multiple regions of alpha-synuclein are associated with Parkinson's disease." Ann Neurol 57(4):535-541.
21. Myhre R, Toft M, Kachergus J, Hulihan MM, Aasly JO, Klungland H, Farrer M J. 2008. "Multiple alpha-synuclein gene polymorphisms are associated with Parkinson's disease in a Norwegian population." Acta Neurol Scand 118(5):320-327.
22. Nicoletti A, Pugliese P, Nicoletti G, Arabia G, Annesi G, De Mari M, Lamberti P, Gallerini S, Marconi R, Epifanio A, Morgante L, Cozzolino A, Barone P, Torchia G, Quattrone A, Zappia M. 2010. "The FRAGAMP study: Environmental and genetic factors in Parkinson's disease, methods and clinical features." Neurol Sci 31(1):47-52.
23. Pankratz N, Nichols WC, Elsaesser VE, Pauciulo MW, Marek DK, Halter CA, Wojcieszek J, Rudolph A, Pfeiffer RF, Foroud T. 2009. "Alpha-synuclein and familial Parkinson's disease." Mov Disord 24(8):1125-1131.
24. Parsian AJ, Racette BA, Zhao JH, Sinha R, Patra B, Perlmutter JS, Parsian A. 2007. "Association of alpha-synuclein gene haplotypes with Parkinson's disease. " Parkinsonism Relat Disord 13(6):343-347.
25. Ross OA, Gosal D, Stone JT, Lincoln SJ, Heckman MG, Irvine GB, Johnston JA, Gibson JM, Farrer MJ, Lynch T. 2007. "Familial genes in sporadic disease: common variants of alpha-synuclein gene associate with Parkinson's disease. " Mech Ageing Dev 128(5-6):378-382.
26. Satake W, Nakabayashi Y, Mizuta I, Hirota Y, Ito C, Kubo M, Kawaguchi T, Tsunoda T, Watanabe M, Takeda A, Tomiyama H, Nakashima K, Hasegawa K, Obata F, Yoshikawa T, Kawakami H, Sakoda S, Yamamoto M, Hattori N, Murata M, Nakamura Y, Toda T. 2009. "Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. " Nat. Genet. 41(12):1303-1307.
27. Singh NK, Banerjee BD, Bala K, Basu M, Chhillar N. 2014. "Gene-Gene and Gene-Environment interaction on the risk of Parkinson's Disease. " Curr Aging Sci. 7(2):101-109.
28. Sutherland GT, Halliday GM, Silburn PA, Mastaglia FL, Rowe DB, Boyle RS, O'Sullivan JD, Ly T, Wilton SD, Mellick GD. 2009. "Do polymorphisms in the familial Parkinsonism genes contribute to risk for sporadic Parkinson's disease?" Mov Disord 24(6):833-838.
29. Tan EK, Chai A, Teo YY, Zhao Y, Tan C, Shen H, Chandran VR, Teoh ML, Yih Y, Pavanni R, Wong MC, Puvan K, Lo YL, Yap E. 2004. "Alpha-synuclein haplotypes implicated in risk of Parkinson's disease. " Neurology 62(1):128-131.
30. Tan EK, Kwok HH, Tan LC, Zhao WT, Prakash KM, Au WL, Pavanni R, Ng YY, Satake W, Zhao Y, Toda T, Liu JJ. 2010. "Analysis of GWAS-linked loci in Parkinson disease reaffirms PARK16 as a susceptibility locus. " Neurology 75(6):508-512.
31. Trotta L, Guella I, Solda G, Sironi F, Tesei S, Canesi M, Pezzoli G, Goldwurm S, Duga S, Asselta R. 2012. "SNCA and MAPT genes: Independent and joint effects in Parkinson disease in the Italian population. " Parkinsonism Relat Disord 18(3):257-262.
32. Wang YS, Shi YM, Wu ZY, He YX, Zhang BZ. 1991. "Parkinson's disease in China. Coordinational Group of Neuroepidemiology, PLA." Chin. Med. J. 104(11):960-964.
33. Westerlund M, Belin AC, Anvret A, Hakansson A, Nissbrandt H, Lind C, Sydow O, Olson L, Galter D. 2008. "Cerebellar alpha-synuclein levels are decreased in Parkinson's disease and do not correlate with SNCA polymorphisms associated with disease in a Swedish material." FASEB J 22(10):3509-3514.
34. Winkler S, Hagenah J, Lincoln S, Heckman M, Haugarvoll K, Lohmann-Hedrich K, Kostic V, Farrer M, Klein C. 2007. "alpha-Synuclein and Parkinson disease susceptibility. " Neurology 69(18):1745-1750.
35. Wirdefeldt K, Gatz M, Pawitan Y, Pedersen NL. 2005. "Risk and protective factors for Parkinson's disease: a study in Swedish twins. " Ann Neurol 57(1):27-33.
36. Zintzaras E, Ioannidis JP. 2005. "Heterogeneity testing in meta-analysis of genome searches. " Genet Epidemiol 28(2):123-137.